{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T21:50:08Z","timestamp":1793137808628,"version":"4.5.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T00:00:00Z","timestamp":1749859200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Natural Science Foundation Project of Chongqing","award":["CSTB2023NSCQ-MSX1101"],"award-info":[{"award-number":["CSTB2023NSCQ-MSX1101"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s00415-025-13099-9","type":"journal-article","created":{"date-parts":[[2025,6,14]],"date-time":"2025-06-14T03:33:15Z","timestamp":1749871995000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Response to telitacicept in optic neuritis associated with Sjogren's syndrome: a case report and literature review"],"prefix":"10.1007","volume":"272","author":[{"given":"Xue","family":"Chen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MingFang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YanLong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HuanZi","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,14]]},"reference":[{"key":"13099_CR1","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.survophthal.2019.10.004","volume":"65","author":"O Bjordal","year":"2020","unstructured":"Bjordal O, Norheim KB, Rodahl E, Jonsson R, Omdal R (2020) Primary Sjogren\u2019s syndrome and the eye. Surv Ophthalmol 65:119\u2013132","journal-title":"Surv Ophthalmol"},{"key":"13099_CR2","doi-asserted-by":"publisher","first-page":"99","DOI":"10.5114\/reum.2018.75521","volume":"56","author":"J Perzynska-Mazan","year":"2018","unstructured":"Perzynska-Mazan J, Maslinska M, Gasik R (2018) Neurological manifestations of primary Sjogren\u2019s syndrome. Reumatologia 56:99\u2013105","journal-title":"Reumatologia"},{"key":"13099_CR3","doi-asserted-by":"publisher","first-page":"e485","DOI":"10.1016\/j.lpm.2012.06.002","volume":"41","author":"AL Fauchais","year":"2012","unstructured":"Fauchais AL, Magy L, Vidal E (2012) Central and peripheral neurological complications of primary Sjogren\u2019s syndrome. Presse Med 41:e485-493","journal-title":"Presse Med"},{"key":"13099_CR4","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.2174\/138161208799316366","volume":"14","author":"S Ozgocmen","year":"2008","unstructured":"Ozgocmen S, Gur A (2008) Treatment of central nervous system involvement associated with primary Sjogren\u2019s syndrome. Curr Pharm Des 14:1270\u20131273","journal-title":"Curr Pharm Des"},{"key":"13099_CR5","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1002\/art.39859","volume":"69","author":"CH Shiboski","year":"2017","unstructured":"Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, Rasmussen A, Scofield H, Vitali C, Bowman SJ, Mariette X, International Sjogren\u2019s Syndrome Criteria Working G (2017) 2016 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for Primary Sjogren\u2019s Syndrome: a consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol 69:35\u201345","journal-title":"Arthritis Rheumatol"},{"key":"13099_CR6","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1097\/OPX.0000000000001054","volume":"94","author":"E Bak","year":"2017","unstructured":"Bak E, Yang HK, Hwang JM (2017) Optic neuropathy associated with primary Sjogren\u2019s syndrome: a case series. Optom Vis Sci 94:519\u2013526","journal-title":"Optom Vis Sci"},{"key":"13099_CR7","doi-asserted-by":"publisher","first-page":"e30","DOI":"10.1016\/j.jcjo.2018.04.013","volume":"54","author":"S Phuljhele","year":"2019","unstructured":"Phuljhele S, Pujari A, Obedulla H, Saxena R, Sharma P (2019) Atypical presentation of primary Sjogren\u2019s syndrome as optic neuritis. Can J Ophthalmol 54:e30\u2013e32","journal-title":"Can J Ophthalmol"},{"key":"13099_CR8","first-page":"888","volume":"6","author":"WQ Tang","year":"2013","unstructured":"Tang WQ, Wei SH (2013) Primary Sjogren\u2019s syndrome related optic neuritis. Int J Ophthalmol 6:888\u2013891","journal-title":"Int J Ophthalmol"},{"key":"13099_CR9","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/ana.410270313","volume":"27","author":"JW Griffin","year":"1990","unstructured":"Griffin JW, Cornblath DR, Alexander E, Campbell J, Low PA, Bird S, Feldman EL (1990) Ataxic sensory neuropathy and dorsal root ganglionitis associated with Sjogren\u2019s syndrome. Ann Neurol 27:304\u2013315","journal-title":"Ann Neurol"},{"key":"13099_CR10","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s10067-010-1458-7","volume":"30","author":"T Gono","year":"2011","unstructured":"Gono T, Kawaguchi Y, Katsumata Y, Takagi K, Tochimoto A, Baba S, Okamoto Y, Ota Y, Yamanaka H (2011) Clinical manifestations of neurological involvement in primary Sjogren\u2019s syndrome. Clin Rheumatol 30:485\u2013490","journal-title":"Clin Rheumatol"},{"key":"13099_CR11","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1097\/01.md.0000141099.53742.16","volume":"83","author":"S Delalande","year":"2004","unstructured":"Delalande S, de Seze J, Fauchais AL, Hachulla E, Stojkovic T, Ferriby D, Dubucquoi S, Pruvo JP, Vermersch P, Hatron PY (2004) Neurologic manifestations in primary Sjogren syndrome: a study of 82 patients. Medicine (Baltimore) 83:280\u2013291","journal-title":"Medicine (Baltimore)"},{"key":"13099_CR12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005194","volume":"95","author":"JY Sun","year":"2016","unstructured":"Sun JY, Liu Z, Zhao P, Liu T (2016) Optic neuritis as an initial presentation of primary Sjogren syndrome: a case report and literature review. Medicine (Baltimore) 95:e5194","journal-title":"Medicine (Baltimore)"},{"issue":"Suppl 118","key":"13099_CR13","first-page":"199","volume":"37","author":"S Gandolfo","year":"2019","unstructured":"Gandolfo S, De Vita S (2019) Double anti-B cell and anti-BAFF targeting for the treatment of primary Sjogren\u2019s syndrome. Clin Exp Rheumatol 37(Suppl 118):199\u2013208","journal-title":"Clin Exp Rheumatol"},{"key":"13099_CR14","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1007\/s40265-021-01591-1","volume":"81","author":"S Dhillon","year":"2021","unstructured":"Dhillon S (2021) Telitacicept: first approval. Drugs 81:1671\u20131675","journal-title":"Drugs"},{"key":"13099_CR15","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1093\/rheumatology\/kead265","volume":"63","author":"D Xu","year":"2024","unstructured":"Xu D, Fang J, Zhang S, Huang C, Huang C, Qin L, Li X, Chen M, Liu X, Liu Y, Li Z, Hu J, Bao C, Wei W, Tian J, Duan X, Zeng X (2024) Efficacy and safety of telitacicept in primary Sjogren\u2019s syndrome: a randomized, double-blind, placebo-controlled, phase 2 trial. Rheumatology (Oxford) 63:698\u2013705","journal-title":"Rheumatology (Oxford)"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13099-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-025-13099-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-025-13099-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T19:29:14Z","timestamp":1757186954000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-025-13099-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,14]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["13099"],"URL":"https:\/\/doi.org\/10.1007\/s00415-025-13099-9","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,14]]},"assertion":[{"value":"20 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflicts of interest relevant to this work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The clinical trial registration number: NCT04078386.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Written informed consent was obtained from the patient for the write-up and publication of this case report and any accompanying images.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Patient consent statement"}}],"article-number":"462"}}